35308082 34305570 29196213 24093081 22814707 25970283 28190394 23339288 28182002 29910000 28170377 26123252 24946076 26982707 33057020 23913659 22229581 30897353 27147665 32260305 31894407 23825679 28821274 31098954 31472250 36443312 23913003 2549364 - Search Results

Year	Number of Results
2012	4
2013	8
2014	7
2015	7
2016	3
2017	9
2018	4
2019	4
2020	4
2021	1
2022	7
2023	0

1

Peripheral inflammatory cytokines and motor symptoms in persons with Parkinson's disease.

Diaz K, Kohut ML, Russell DW, Stegemöller EL. Diaz K, et al. Brain Behav Immun Health. 2022 Mar 7;21:100442. doi: 10.1016/j.bbih.2022.100442. eCollection 2022 May. Brain Behav Immun Health. 2022. PMID: 35308082 Free PMC article.

2

A pH-eQTL Interaction at the RIT2-SYT4 Parkinson's Disease Risk Locus in the Substantia Nigra.

Patel S, Howard D, French L. Patel S, et al. Front Aging Neurosci. 2021 Jul 9;13:690632. doi: 10.3389/fnagi.2021.690632. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34305570 Free PMC article.

3

Ifngr1 and Stat1 mediated canonical Ifn-γ signaling drives nigrostriatal degeneration.

Strickland MR, Koller EJ, Deng DZ, Ceballos-Diaz C, Golde TE, Chakrabarty P. Strickland MR, et al. Neurobiol Dis. 2018 Feb;110:133-141. doi: 10.1016/j.nbd.2017.11.007. Epub 2017 Nov 28. Neurobiol Dis. 2018. PMID: 29196213 Free PMC article.

4

Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.

Ramanan VK, Saykin AJ. Ramanan VK, et al. Am J Neurodegener Dis. 2013 Sep 18;2(3):145-75. Am J Neurodegener Dis. 2013. PMID: 24093081 Free PMC article. Review.

5

Inflammation in Parkinson's disease.

Tufekci KU, Meuwissen R, Genc S, Genc K. Tufekci KU, et al. Adv Protein Chem Struct Biol. 2012;88:69-132. doi: 10.1016/B978-0-12-398314-5.00004-0. Adv Protein Chem Struct Biol. 2012. PMID: 22814707 Review.

6

Interferon-alpha caused reversible parkinsonism.

Lu CS, Kao WY, Lin JC, Chang PY. Lu CS, et al. Clin Neuropharmacol. 2015 May-Jun;38(3):119-20. doi: 10.1097/WNF.0000000000000087. Clin Neuropharmacol. 2015. PMID: 25970283

7

Neuroprotective Effect of Atremorine in an Experimental Model of Parkinson's Disease.

Carrera I, Fernandez-Novoa L, Sampedro C, Cacabelos R. Carrera I, et al. Curr Pharm Des. 2017;23(18):2673-2684. doi: 10.2174/1381612823666170210143530. Curr Pharm Des. 2017. PMID: 28190394

8

Review: microglia in protein aggregation disorders: friend or foe?

Gentleman SM. Gentleman SM. Neuropathol Appl Neurobiol. 2013 Feb;39(1):45-50. doi: 10.1111/nan.12017. Neuropathol Appl Neurobiol. 2013. PMID: 23339288 Free PMC article. Review.

9

Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease.

Zhang Y, He X, Wu X, Lei M, Wei Z, Zhang X, Wen L, Xu P, Li S, Qu S. Zhang Y, et al. Cell Death Dis. 2017 Feb 9;8(2):e2611. doi: 10.1038/cddis.2016.491. Cell Death Dis. 2017. PMID: 28182002 Free PMC article.

10

Biallelic Mutations in MYORG Cause Autosomal Recessive Primary Familial Brain Calcification.

Yao XP, Cheng X, Wang C, Zhao M, Guo XX, Su HZ, Lai LL, Zou XH, Chen XJ, Zhao Y, Dong EL, Lu YQ, Wu S, Li X, Fan G, Yu H, Xu J, Wang N, Xiong ZQ, Chen WJ. Yao XP, et al. Neuron. 2018 Jun 27;98(6):1116-1123.e5. doi: 10.1016/j.neuron.2018.05.037. Epub 2018 Jun 14. Neuron. 2018. PMID: 29910000 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results